HomeRPHM • NASDAQ
add
Reneo Pharmaceuticals Inc
Previous close
$1.67
Year range
$0.98 - $10.98
Market cap
55.81M USD
Avg Volume
104.51K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Market news
Financials
Income Statement
Revenue
Net income
(USD) | Dec 2023info | Y/Y change |
---|---|---|
Revenue | — | — |
Operating expense | 24.36M | 67.45% |
Net income | -23.55M | -73.19% |
Net profit margin | — | — |
Earnings per share | -0.71 | -29.09% |
EBITDA | -24.31M | -67.44% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
(USD) | Dec 2023info | Y/Y change |
---|---|---|
Cash and short-term investments | 102.96M | 1.77% |
Total assets | 107.44M | -0.69% |
Total liabilities | 18.83M | 129.25% |
Total equity | 88.61M | — |
Shares outstanding | 33.42M | — |
Price to book | 0.63 | — |
Return on assets | -51.21% | — |
Return on capital | -59.21% | — |
Cash Flow
Net change in cash
(USD) | Dec 2023info | Y/Y change |
---|---|---|
Net income | -23.55M | -73.19% |
Cash from operations | -19.75M | -26.52% |
Cash from investing | 39.78M | 247.77% |
Cash from financing | -4.13M | -1,370.15% |
Net change in cash | 15.90M | 137.66% |
Free cash flow | -9.78M | 8.46% |
About
Founded
2014
Headquarters
Website
Employees
8